EXPIRED
Department of Health and Human Services
Participating Organizations
National Institutes of
Health (NIH) (http://www.nih.gov)
Components of Participating Organizations
National Institute of
Environmental Health Sciences (NIEHS) (http://www.niehs.nih.gov)
Title: Superfund
Basic Research and Training Program (P42)
Announcement Type
This is a reissue of RFA-ES-07-006.
Update: The following update relating to this announcement has been issued:
Request For Applications (RFA) Number: RFA-ES-08-005
Catalog of
Federal Domestic Assistance Number(s)
93.113, 93.115, 93.143
Key Dates
Release
Date: October 1, 2008
Letters of
Intent Receipt Date: March 16,
2009
Application
Receipt Date: April 15, 2009
Peer Review Date: October 2009
Council
Review Date: January 2010
Earliest Anticipated Start Date: April 1, 2010
Additional Information To Be Available Date (Url Activation
Date): Not Applicable
Expiration
Date: April 16, 2009
Due
Dates for E.O. 12372
Not Applicable
Additional Overview
Content
Executive Summary
Table of Contents
Part I
Overview Information
Part II Full Text of Announcement
Section I. Funding Opportunity
Description
1. Research Objectives
Section II. Award Information
1. Mechanism of Support
2. Funds Available
Section III. Eligibility Information
1. Eligible Applicants
A. Eligible Institutions
B. Eligible Individuals
2. Cost Sharing or Matching
3. Other - Special Eligibility Criteria
Section
IV. Application and Submission Information
1. Address to Request Application Information
2. Content and Form of Application Submission
3. Submission Dates and Times
A. Receipt and Review and
Anticipated Start Dates
1. Letter of
Intent
B. Sending an Application to
the NIH
C. Application Processing
4. Intergovernmental Review
5. Funding Restrictions
6. Other Submission Requirements and Information
Section
V. Application Review Information
1. Criteria
2. Review and Selection Process
A. Additional Review Criteria
B. Additional Review Considerations
C. Resource Sharing Plan(s)
3.
Anticipated Announcement and Award Dates
Section
VI. Award Administration Information
1. Award Notices
2. Administrative and National Policy Requirements
3. Reporting
Section
VII. Agency Contact(s)
1. Scientific/Research Contact(s)
2. Peer Review Contact(s)
3. Financial/ Grants Management Contact(s)
Section
VIII. Other Information - Required Federal Citations
Part II
- Full Text of Announcement
Section I. Funding Opportunity Description
1.
Research Objectives
Purpose
The National Institute of Environmental Health Sciences (NIEHS) invites qualified investigators from domestic institutions of higher education to submit an application for a Superfund Basic Research and Training Program (SBRP) multi-project program grant. With the assignment of the SBRP to NIEHS, the goal of the Program is to improve public health by supporting integrative research that is multidisciplinary in nature and includes the ability to identify, assess, and evaluate the potential health effects of exposure to hazardous substances and to develop innovative chemical, physical and biological technologies for reducing potential exposure to hazardous substances.
Applicants responding to this FOA are expected to develop an over-arching conceptual theme to guide the scientific direction of the Program s interdisciplinary/multidisciplinary research team. It is expected that the overall theme will foster collaboration, whereby projects are integrated and specific emphasis is placed on interactions between the biomedical and non-biomedical research projects.
Ultimately, decisions needed to protect human health must be based on mechanistic knowledge gained from the integration of available data from all relevant research disciplines such as toxicology, molecular biology, epidemiology, geology, ecology and engineering. It is expected that the development of integrated and inter-disciplinary research programs will result in an extraordinary level of synergy and technology-transfer opportunities, the outcomes of which have the potential to: (1) improve our understanding of the relationship between exposure and disease; (2) accelerate the development of public health prevention/intervention strategies to improve human health, as well as reduce the risk of exposure to toxic substances found at hazardous waste sites; (3) translate basic non-biomedical research into efficient and cost-effective cleanup strategies; and (4) improve the decision-making process at sites by reducing the uncertainty in human and ecological risk assessments. All are important goals of the SBRP.
Background
The SBRP was created under the Superfund Amendments and Reauthorization Act (SARA) of 1986, when it was realized that that the strategies and technologies for the cleanup of Superfund sites were inadequate to address the magnitude and complexity of the problem. The mandates under which the SBRP operates provides a framework that has allowed NIEHS the flexibility to create a university-based, multi-project research program for conducting science to address the wide array of scientific uncertainties facing the national Superfund program. These mandates include the development of (1) methods and technologies to detect hazardous substances in the environment; (2) advanced techniques for the detection, assessment, and evaluation of the effect on human health of hazardous substances; (3) methods to assess the risks to human health presented by hazardous substances; and (4) basic biological, chemical, and physical methods to reduce the amount and toxicity of hazardous substances.
The assignment of the SBRP to the NIEHS underscores an emphasis on the human health effects resulting from exposure to hazardous substances. However, the Program also supports non-traditional NIH research such as the modeling of fate and transport processes for chemical contaminants and the development of remediation technologies to improve the quality of the environment as a means to reduce exposure and its potential impact on human health. Clearly integration from many different disciplines is needed to address the complex, interdependent yet fundamental issues that arise in relation to hazardous waste. Accordingly, the structure of the Program requires the integration of biomedical, ecological, geological and engineering sciences in order to develop and apply a full range of primary prevention strategies. Ultimately, this holistic approach will enable the transitioning of basic research findings into epidemiological, clinical, ecological and remediation studies which will be important for the decision-making process to protect health. This approach is exemplified by the research being conducted by the Program, see http://tools.niehs.nih.gov/sbrp/programs/index275.cfm.
Research Scope
A central premise of the SBRP is that there is a link between chemical exposure and disease outcome, and that understanding/identifying this link will help to establish new or improved prevention/intervention modalities. Therefore, research supported by the SBRP should emphasize basic and applied research, using state-of-the-art techniques to improve the sensitivity and specificity for detecting adverse effects in humans or in ecosystems exposed to hazardous substances, as well as for developing a better understanding of the underlying biology responsible for these adverse effects. Moreover, the applicant should emphasize research that studies the phenomena affecting transport, fate and transformation of hazardous substances, and develop remediation strategies that attenuate and mitigate exposure as necessary to protect human health and ecosystems.
In addition to the strong basic research focus of the Program, there is an equally important commitment to create an environment that fosters the translation of the scientific accomplishments emanating from the Program to its stakeholders -- whether to industry via technology transfer, to the government through partnerships, or to the public through community outreach. Therefore, research translation is a required element. The training of the next generation of scientists (i.e., graduate, post-doctoral) in interdisciplinary research, and conducting community outreach are highly valued activities and are strongly encouraged.
Goals and Objectives
This FOA encourages the development of multi-project, interdisciplinary research programs with the ultimate purpose of reducing the burden of human illness and dysfunction from environmental causes. Each interdisciplinary research program should develop an overall conceptual theme that fosters collaboration, whereby projects are integrated, and specific emphasis is placed on interactions between the biomedical and non-biomedical research projects to promote the goals of the SBRP. These goals include
Suggested Chemicals
Research must be conducted in the context of:
Note: the applicant should refer to the following websites for information on hazardous substances that are relevant to US Environmental Protection Agency (EPA) Superfund program and to the Agency for Toxic Substances and Disease Registry (ATSDR) (http://www.atsdr.cdc.gov/cercla). In addition, the applicant is strongly encouraged to visit the SBRP website s Additional Resources page at http://www.niehs.nih.gov/research/supported/sbrp/funding/rfa_resources.cfm
to determine how research that may be proposed fills research gaps or needs not currently addressed within the Program http://tools.niehs.nih.gov/sbrp/programs/index275.cfm.
Suggested Research Topics
The development of a thematic concept for an SBRP application can be focused in many different ways. Often programs are driven thematically by a particular chemical or class of chemicals; by a common mechanistic pathway such as oxidative stress; by a particular disease, dysfunction or organ system such as the neurological system; or by methodological approaches such as biomarker development or the use of omic technologies. Within this context, the applicant should propose individual biomedical and non-biomedical research projects.
Specific Research Needs
There are some specific research needs and new directions within the Program that applicants may wish to consider. These include:
Broad Research Themes
In addition to the specific research needs listed above, examples of broad scientific themes relevant to the SBRP are provided. These examples are meant to stimulate the thinking of potential applicants by illustrating interdisciplinary linkages between scientific disciplines, and, ultimately, how this knowledge enhances public and environmental health. These examples are not intended to be exhaustive. The applicant is also directed to the following site (http://www.niehs.nih.gov/research/supported/sbrp/funding/rfa.cfm) for the Suggested Research Topics document which lists additional research topics and approaches of interest to the SBRP.
Mechanistically-Based Biomedical Research. Understanding the mechanisms whereby toxicants induce adverse human health effects is central to the SBRP. It is believed that environmental factors contribute to the etiology of most human diseases/dysfunctions (e.g., reproductive, immune competence, pulmonary/cardiovascular, cancer, neurodevelopment, neurobehavioral, congenital defects, renal, etc.). Therefore, the SBRP seeks to support mechanistic research that includes laboratory-based and population-based studies for unraveling critical biological pathways that contribute to disease when perturbed by environmental contaminants. Research should focus on environmentally related diseases and pathways of toxicological significance in the exposure-disease paradigm.
Susceptibility and Predisposition Research. A critical confounding factor underlying the physiological consequences of exposure to hazardous substances is the genetic variability inherent in the population. This variability can lead to sub-populations with unique genetic characteristics that enhance their sensitivity to environmental contaminants or other external insults. The Program recognizes the importance of identifying susceptible populations in order to develop strategies to reduce their burden of environmentally-influenced diseases. It is encouraged that collaborative efforts between biologists, epidemiologists, statisticians, systems engineers, and computer scientists be considered in order to integrate the available information from animal and human studies in such a manner that would inform the risk assessment process.
Exposure Assessment Research. A priori, an environmentally-influenced disease implies that exposure has occurred within some temporal, spatial framework in relation to the development of disease. Unfortunately, exposure is one of the most difficult parameters to measure due, in part, to the lack of precision in the methods to integrate exposure over time, the inability to characterize the attributable risk from multiple exposures experienced over one’s lifetime and the lack of statistical and computational approaches to measure complex gene-environment interactions. Because exposure assessment is so integral to decisions related to protecting human health and ecosystems, understanding the complexities that impact exposure is an important research focus for the SBRP. Exposure assessment within the context of the SBRP falls within three interconnected research domains, (a) site characterization, (b) bioavailability and (c) accurate body burden and response measurements. These are further discussed below.
a) Site Characterization: The ability to predict the risk of exposure to contaminants at hazardous waste sites is dependent upon understanding the physical, chemical and geological characteristics of the site. Therefore, site characterization is an integral component of the exposure assessment paradigm. The SBRP seeks to support research that improves site characterization so that the knowledge gained can be incorporated into the exposure assessment paradigm.
b) Bioavailability: Bioavailability of a contaminant describes the degree to which it is available for transformation, and transport within environmental media (i.e., soil, sediments and surface and groundwater), as well as the degree by which a contaminant eventually is assimilated by organisms. As an integrating principle, bioavailability crosses all scientific disciplines and is an important factor to consider in understanding the fate and transport of hazardous substances; the ability of hazardous substances to be internalized by microbes, wildlife and humans; and the ability once internalized to be available to tissues and organs. Recent technological advances provide new opportunities to study the complex issues surrounding bioavailability.
c) Quantifying Body Burden and Response: The integration of available data from site characterization and bioavailability studies into exposure and risk assessment models provides a means to predict potential exposure levels in human populations and ecosystems. The validation of these models requires the development and application of new methods and technologies that can measure the extent of exposure in disparate populations. Many approaches are available that have the requisite sensitivity and specificity to detect current exposures, or measure contaminants that have a long half-life in biological systems. However, the issues of past exposures and exposure to mixtures are still intractable problems. Hence, SBRP seeks research that accounts for concurrent or sequential routes of exposure to a large number of chemicals over varying periods of time.
Remediation Research. The SBRP supports the application of engineering and microbial sciences as prevention (i.e., remediation) strategies to improve human health by mitigating exposure and reducing toxicity of environmental contaminants at hazardous waste sites. SBRP seeks research that is focused on the scientific principles and underlying processes that drive different remediation technologies as methods to clean up persistent toxicants in groundwater, sediments and soils. Also important is research that focuses on the translation of these basic principles into efficient and cost-effective technologies to reduce the level of contaminants present in the environment. Accordingly, the SBRP encourages a continuum of research that ranges from basic mechanistic research to technology development.
Ecological Research. Understanding the ecological impacts resulting from exposure to contaminants found at hazardous waste sites is an important research theme relevant to SBRP and interfaces biology, ecology, microbiology, bioengineering and engineering sciences. An integrated approach is also critical to reducing uncertainty in environmental risk assessments, another important objective of the SBRP. Capitalizing on state-of-the-art methods and genetic approaches that have been primarily applied to human studies provides tools that could be of benefit in advancing the ecological sciences. Accordingly, the SBRP encourages the application of omics tools, new sensor technologies and informatics with the goal of enhancing our understanding of ecological succession and biodiversity as a function of exposure to contaminants.
Mixtures. A critical issue related to hazardous waste sites for remediation or health effects research is that the concentrations at which chemicals occur in the environment are extremely low and exposures are long-term, continual, with simultaneous exposure to multiple chemicals. Whether one considers remediation strategies, exposure to humans or ecosystems, site characterization, bioavailability or the development of risk assessment models, chemical mixtures are an issue of concern. Furthermore, biomedical research, exposure assessments or remediation strategies based on exposures to single substances in isolation are rarely reflected in real-life scenarios. Hence, the SBRP seeks to support research that considers the effects of mixtures. With the continued development and refinement in the available repertoire of advanced tools and approaches, the scientific community may be in a better position to assess the impact of mixtures on all areas of research important to the SBRP.
Risk Assessment. The risk assessment process defines exposures of concern and potential threats. Historically, risk assessments are focused on developing models for either human health or ecological health and decisions are made accordingly. However, within the interdisciplinary framework of the SBRP, opportunities to develop integrated models that incorporate both human and ecological effects need to be encouraged in order to assist in making cost-effective and protective decisions. In addition, the translation of the knowledge gained from high data content approaches, which are increasingly being used to obtain mechanistic data, will require the development of a new generation of risk assessment models. These models will need to take into account biological pathways and networks, susceptible populations, low dose effects and mixtures. Therefore, the SBRP is interested in innovative approaches to risk assessment utilizing research focused on the development of: (1) large datasets to be used in model development, (2) tools to integrate diverse datasets and (3) new risk assessment models that incorporate these diverse datasets.
For more examples of each of the above Broad Research Themes, applicants are encouraged to refer to the Suggested Research Topics document on the following website (http://www.niehs.nih.gov/research/supported/sbrp/funding/rfa.cfm).
CORES Required and Optional Program Components
Although novel, innovative, cutting-edge research projects are the nucleus of an SBRP grant, it is the intent of the SBRP that the research activities be integrated into an interdisciplinary program. In support of this goal, NIEHS requires the establishment of cores. Each grant application is required to have an Administrative Core, a Research Translation Core, and at least one Research Support Core. Community Outreach and Training Cores may also be included in support of achieving a truly multidisciplinary approach to hazardous substances research.
Administrative Core (required component). The Administrative Core is a required component of a program. Through this core the Principal Investigator provides leadership and guidance in fulfilling the stated objective of his or her program. To accomplish this, the applicant should create within the Administrative Core an infrastructure that promotes cross-discipline interactions among all of the projects and cores. The structure of this Core should provide the Principal Investigator with a mechanism for
The applicant should include a plan for conducting the administrative functions of the core, a description of the lines of communication among the program scientists, and a description of the mechanisms to be used to encourage and ensure the integration and interaction between the biomedical and non-biomedical projects within the program.
To aid the Principal Investigator in achieving the goals set forth for his or her program, the establishment of an External Advisory Committee is required. Its role is to provide guidance to the Principal Investigator in the following areas:
The composition of the committee should include appropriate scientific expertise, as well as represent appropriate stakeholder interests. For example, not only should the academic community be represented on the committee, but also other stakeholders, such as industry, community or government representatives.
Research Translation Core (required component). NIEHS recognizes the importance of translating important research outcomes to appropriate audiences, thereby encouraging the accurate and timely use of these research products. Accordingly, NIEHS requires the inclusion of a Research Translation Core in each SBRP grant. For the purpose of this FOA, the SBRP defines Research Translation as communicating and facilitating the use of research findings emanating from the Program in the manner most appropriate for their application and the advancement of research objectives. As described below, NIEHS requires that this core be comprised of three specific activities: (a) partnering with governmental agencies, (b) conducting technology transfer and (c) communicating to broad audiences.
a) Partnerships with Government Agencies: Establishing ongoing communication with the federal, state and/or local agencies charged with protecting human health and the environment is of high importance. In order to address this need, each applicant should:
Note: Applicants are not required to conduct Superfund site-specific activities; however, if site activities are planned, these activities must be conducted in coordination with appropriate federal or state site officials. Therefore applicants should:
b) Technology Transfer: It is important that each program establish a mechanism to facilitate the transfer of technologies and other research generated by the grantee into the hands of an end-user. In order to meet this objective, each applicant should include a plan for:
c) Communicating to Broad Audiences: Beyond government officials and the marketplace, there are other stakeholders who should have timely access to SBRP research findings. A variety of mechanisms to reach these stakeholders are appropriate activities for the Research Translation Core.
In order to demonstrate how the applicant will meet this need, he/she should
In addition, NIEHS considers communication with SBRP associated staff to be a high priority and places this responsibility within the Research Translation Core. NIEHS requires that a plan be established for ensuring the effective communication and transfer of important research findings and other program outcomes to NIEHS. This plan should also include a direct line of communication between the Administrative Core and the Research Translation Core.
Research Support Cores (required component). The SBRP requires at least one Research Support Core. The intent is that this Core will provide essential, centralized services or resources that will result in an economy of effort and/or savings in the overall costs of a program. Well designed cores also serve as a useful tool in promoting interdisciplinary activities. By definition, a Research Support Core must support two or more research projects. Typical Core facilities include laboratory facilities, biostatistics and/or bioinformatics support, or analytical equipment and services. The applicant should include in his/her description of these cores the services to be rendered, the methodological approaches to be used and a plan for prioritizing the use of the facility by program members.
Community Outreach Core (optional component). The SBRP strongly encourages the applicant to consider the inclusion of a Community Outreach Core. Outreach to communities is in line with the Superfund Program’s mandate to more actively involve the community in the decision-making process. The Core should be designed with a primary focus on health-related issues; however, other topics of interest to the community such as environmental concerns are also acceptable. It is expected that the Core will complement the research strengths of the program.
For the purpose of this FOA, the SBRP defines community outreach as extending support or guidance to communities, community advocates or community organizations. Appropriate target communities include those that (1) are living in proximity to, or affected by hazardous waste sites or (2) are exposed to hazardous substances via other pathways. For example, appropriate community groups could include local government, tribal councils, established groups/organizations focused specifically on local environmental/site issues, or community service groups focused on educating the community about local issues. As an outgrowth of this activity, it is expected that interactions with the community will also serve to enhance the program’s research agenda.
Community outreach activities should be conducted in full partnership with the target community. In other words, the community should participate in the design and approach of the activity at the onset of the project. Note: Any activities conducted at Superfund sites should be coordinated with the appropriate offices in EPA or ATSDR. Likewise, activities conducted at state or tribal sites should be coordinated with appropriate state or tribal agencies. This will ensure that the applicant efforts are not in conflict with nor duplicate other agencies activities. However, this coordination should not compromise the independence of the outreach efforts since the community may value the support of a non-regulatory agency.
Community outreach activities may be either very broad or very focused. Examples that are appropriate for a Community Outreach Core are
It is important that the Community Outreach Core define the approach it will use to identify a community/organizational unit with which it proposes to collaborate. It should develop a plan detailing the objectives and the methods (e.g., conducting small group discussion or listening sessions, producing informational materials, providing leadership mentoring, etc.) that will be used in establishing and maintaining involvement with the community. The SBRP anticipates that each Community Outreach Core will include in its plan how it will measure milestones or outcomes of these activities. (See Section III.3 for budget details).
Training Core (optional component). SBRP strongly encourages applicants to include a Training Core, which supports graduate level cross-disciplinary training in fields related to environmental health. The Training Core should reflect the interdisciplinary nature of the overall research effort of the program. It is anticipated that the training core will enhance cross training of students and post-doctoral fellows in disciplines not traditionally linked in the university graduate structure. Students pursuing degrees in the non-biomedical areas should be encouraged to place their studies in the context of environmental health sciences and biomedical research. Likewise, students of the biomedical sciences should have cross training opportunities in the non-biomedical areas of study.
In addition to providing students with unique opportunities in interdisciplinary research, the SBRP also encourages the Training Cores to provide students with practical opportunities for communicating research outcomes to diverse audiences. For example, all researchers need to know how to explain their work in a manner easily understood by the intended audience whether the audience be the public or professionals in other areas of science. Another unique opportunity for students of the SBRP is the participation in the Community Outreach Core. The SBRP encourages the Training Core to formally support cross training of this nature. Opportunities such as this will provide students with valuable insights on the full cycle of the research that they conduct.
NOTE: The training of pre- and post-doctoral students may be carried on outside the structured Training Core. In these cases, the budgets for these students should be part of the project or core budgets rather than the Training Core budget. In keeping with the NIH efforts to train members of minority groups, and those with disabilities, applicants are encouraged to consider these candidates in their recruitment efforts. (See Section III.3 for budget details).
See Section VIII, Other Information - Required Federal Citations, for policies related to this announcement.
1. Mechanism of Support
This funding opportunity announcement (FOA) will use the P42 award mechanism. The applicant will be solely responsible for planning, directing, and executing the proposed project.
This FOA uses Just-in-Time information concepts. It also uses non-modular budget formats described in the PHS 398 application instructions (see http://grants.nih.gov/grants/funding/phs398/phs398.html).
2. Funds Available
Although
the financial plans of the NIEHS provide support for this Program, the funds
that are appropriated for the SBRP are determined each year according to the
Federal budget process. Because the funding level of this Program may vary
from year to year, awards pursuant to this FOA are contingent upon the
availability of funds and the receipt of a sufficient number of meritorious
applications. The size and duration of each award may vary based on Program
balance and the availability of funds, in addition to the scientific merit
considerations of the review.
Facilities and Administrative (F&A) costs incurred by requesting third party consortia or subcontracts are not included in the direct cost limitation see NOT-OD-05-004. Applications that exceed the stated allowable budget caps for the first year will be returned as non-responsive to this FOA.
NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made in response to this FOA.
Section III. Eligibility Information
1. Eligible Applicants
1.A.
Eligible Institutions
You may submit (an) application(s) if your organization has any of the following characteristic:
Section 311(a)(3) of SARA limits recipients of awards to "accredited institutions of higher education," which are defined in the Higher Education Act, 20 USC (annotated) 3381. However, grantees are permitted under the law, and encouraged by NIEHS, to subcontract as appropriate with organizations, domestic or foreign, public or private (such as universities, colleges, hospitals, laboratories, faith-based organizations, units of State and local governments, and eligible agencies of the Federal government) as necessary to conduct portions of the research. Examples of other organizations may include generators of hazardous wastes; persons involved in the detection, assessment, evaluation, and treatment of hazardous substances; owners and operators of facilities at which hazardous substances are located; State and local governments and community organizations.
1.B. Eligible Individuals
Any individual with the skills, knowledge, and resources necessary to carry out the proposed research is invited to work with his/her institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.
2. Cost Sharing or Matching
This program does not
require cost sharing as defined in the current NIH
Grants Policy Statement.
3. Other-Special Eligibility Criteria
Applicants
must propose a multi-project, multi-disciplinary research program that
addresses a central theme and that is related to the goals of the SBRP. This
multidisciplinary effort should bring together investigators from different
scientific disciplines to direct discrete Research Projects, each of which is
to be related to the central theme developed for the applicant’s program. It
is expected that the research team will include the expertise required to
perform the research proposed and be comprised of scientists that represent the
biomedical and non-biomedical (i.e., engineering, geology, microbiology,
ecology, etc.) fields of study.
The applicant must name a Principal Investigator as the designated leader of the SBRP multi-project grant to provide scientific and administrative leadership to the program. The Principal Investigator must commit a minimum of 1.8 person months to the administration of the program.
In order to be considered for funding each applicant must successfully meet the following minimum requirements:
In addition to these required program components, it is important for the applicant to recognize that the SBRP is more than a basic research program and is strongly encouraged to make investments in other areas crucial to the Program. These include:
Applicants may submit a resubmission application, but such application must include an Introduction addressing the previous peer review critique (Summary Statement).
Applicants may submit a renewal application.
Section IV. Application and Submission Information
1.
Address to Request Application Information
The PHS 398 application
instructions are available at http://grants.nih.gov/grants/funding/phs398/phs398.html in an interactive format. Applicants must use the currently approved version of
the PHS 398. For further assistance contact GrantsInfo, Telephone (301)
710-0267, Email: [email protected].
Telecommunications for
the hearing impaired: TTY 301-451-5936.
2. Content and Form of
Application Submission
Applications must be
prepared using the most current PHS 398 research grant application instructions
and forms. Applications must have a D&B Data Universal Numbering System
(DUNS) number as the universal identifier when applying for Federal grants or
cooperative agreements. The D&B number can be obtained by calling (866)
705-5711 or through the web site at http://www.dnb.com/us/.
The D&B number should be entered on line 11 of the face page of the PHS 398
form.
The title and number of this funding opportunity must be typed in item (box) 2
only of the face page of the application form and the YES box must be checked.
Additional information is available in the PHS 398 grant application instructions.
3. Submission Dates and Times
Applications must be received on or before the receipt date described below in Section IV.3.A.
3.A. Receipt, Review and Anticipated Start Dates
Letters
of Intent Receipt Date: March 16, 2009
Application Receipt Date: April 15, 2009
Peer Review Date: October 2009
Council Review
Date: January 2010
Earliest
Anticipated Start Date: April 1, 2010
3.A.1. Letter of Intent
Prospective applicants are asked to submit a letter of intent that includes the following information:
Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows NIEHS staff to estimate the potential review workload and plan the review.
The
letter of intent is to be sent by the date listed in Section
IV.3.A.
The letter of
intent should be sent to:
Leroy
Worth, Ph.D.
Scientific Review Branch
Division of Extramural Research and Training
National Institute of Environmental Health Sciences
PO Box 12233, EC-30
111 T.W. Alexander Drive
Research Triangle Park, NC 27709
Telephone: (919) 541-0670
FAX: (919) 541-2503
Email: [email protected]
3.B. Sending an Application to the NIH
Applications
must be prepared using the research grant application forms found in the PHS
398 instructions for preparing a research grant application. Submit a signed,
typewritten original of the application, including the checklist, and three
signed photocopies in one package to:
Center for
Scientific Review
National Institutes of Health
6701 Rockledge Drive, Room 1040, MSC 7710
Bethesda, MD 20892-7710 (U.S. Postal Service Express
or regular mail)
Bethesda, MD 20817 (for express/courier service;
non-USPS service)
Personal deliveries of applications are no longer permitted (see http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-040.html).
At
the time of submission, two additional copies of the application and all copies
of the appendix materials must be sent to:
Leroy Worth, Ph.D.
Scientific Review Branch
Division of Extramural Research and Training
National Institute of Environmental Health Sciences
PO Box 12233, EC-30
111 T.W. Alexander Drive
Research Triangle Park, NC 27709
Telephone: (919) 541-0670
FAX: (919) 541-2503
Email: [email protected]
Applications must be received on or before the application
receipt/ date(s) described above (Section
IV.3.A.). If an application is received after that date, it will be
returned to the applicant without review.
Upon receipt,
applications will be evaluated for completeness by CSR and responsiveness by
the National Institute of Environmental Health Sciences. Incomplete and
non-responsive applications will not be reviewed.
The NIH will not
accept any application in response to this funding opportunity that is
essentially the same as one currently pending initial merit review unless the
applicant withdraws the pending application. The NIH will not accept any
application that is essentially the same as one already reviewed. However, the
NIH will accept a resubmission application, but such application must include
an Introduction addressing the critique from the previous review.
Information on the status of an application should be checked by the Principal Investigator in the eRA Commons at: https://commons.era.nih.gov/commons/.
4. Intergovernmental Review
This initiative is not
subject to intergovernmental
review.
5. Funding Restrictions
All NIH awards are
subject to the terms and conditions, cost principles, and other considerations
described in the NIH Grants Policy Statement. The Grants Policy Statement can
be found at NIH Grants
Policy Statement.
Pre-award costs
are allowable. A grantee may, at its own risk and without NIH prior approval,
incur obligations and expenditures to cover costs up to 90 days before the
beginning date of the initial budget period of a new or renewal award if such costs: (1) are
necessary to conduct the project, and (2) would be allowable under the grant,
if awarded, without NIH prior approval. If specific expenditures would
otherwise require prior approval, the grantee must obtain NIH approval before
incurring the cost. NIH prior approval is required for any costs to be incurred
more than 90 days before the beginning date of the initial budget period of a
new or renewal award.
The incurrence of pre-award costs in anticipation of a
competing or non-competing award imposes no obligation on NIH either to make
the award or to increase the amount of the approved budget if an award is made
for less than the amount anticipated and is inadequate to cover the pre-award
costs incurred. NIH expects the grantee to be fully aware that pre-award costs
result in borrowing against future support and that such borrowing must not
impair the grantee's ability to accomplish the project objectives in the
approved time frame or in any way adversely affect the conduct of the project
(see NIH Grants Policy Statement http://grants.nih.gov/grants/policy/nihgps_2003/NIHGPS_Part6.htm.)
6. Other Submission Requirements and Information
A. Application Guidelines. The applications submitted in response to this FOA are complex, and the scientific and programmatic information needed to adequately assess a grant proposal is not fully accommodated within the instructions accompanying the PHS 398 form. Therefore, applicants need to follow the detailed guidelines that are provided in the Application Guidelines document, found on http://www.niehs.nih.gov/research/supported/sbrp/funding/rfa.cfm, to supplement the PHS 398 instructions.
In general an SBRP grant proposal will consist of the following categories of information:
Section l. This section consolidates the budget information, the list of all professional and non-professional personnel, biosketches for all key personnel, institutional environment and resources and tables of core utilization and use of human subjects/vertebrate animals for the entire applicant’s program.
Section ll. This section is unique to a multi-project application. The information requested in this section, for the most part, is not covered in the PHS 398 and includes: an overall introduction and description of the program that incorporates the major theme, goals and objectives, the multi-disciplinary nature of the program and the interactions between the projects and cores; a description of the role of the Principal Investigator; a description of the organizational structure of the applicant s program including an administrative and a management plan to achieve an integrated coordinated research program; and for competing renewals, a general progress report. For resubmission (amended) applications, an additional introduction section is required.
Section lll- Vlll. These sections contain the research plans for the individual research projects, research support cores, administrative, research translation, community outreach and training cores and follow the guidelines established in the PHS 398.
Section lX-Xl. These sections include the Plan for Data Sharing, the Checklist and Appendix materials.
B. Quality Assurance Statement. Quality Assurance Statements will be necessary ONLY for Research Support Cores that provide analytical, quantitative services to the applicant’s program.
EPA regulations as stated in 40CFR30.54 require the inclusion of a Quality Assurance Narrative Statement (QANS, OMB # 2080-0033, approved 8/14/97) for any project application involving data collection or processing, environmental measurements, and/or modeling. The QANS provides information on how quality processes or products will be assured. NIEHS cannot consider applications incomplete without this statement; however, it requests that the QANS be included with all applications that contain analytical and quantitative cores. For awards that involve environmentally related measurements or data generation, a quality system that complies with the requirements of ANSI/ASQC E4, "Specifications and Guidelines for Quality Systems for Environmental Data Collection and Environmental Technology Programs," must be in place. The Quality Assurance Statement should not exceed two pages. This Statement should, for each item listed below, present the required information, reference the specific page and paragraph number of the project description containing the information, or provide a justification as to why the item does not apply to the proposed research.
1. Discuss the activities to be performed or hypothesis to be tested and criteria for determining acceptable data quality. (Note: Such criteria may be expressed in terms of precision, accuracy, representativeness, completeness, and comparability or in terms of data quality objectives or acceptance criteria. Furthermore, these criteria must also be applied to determine the acceptability of existing or secondary data to be used in the project. In this context secondary data may be defined as data collected for other purposes or from other sources, including the literature, compilations from computerized data bases, or results from mathematical models of environmental processes and conditions.)
2. Describe the study design, including sample type and location requirements, all statistical analyses that were or will be used to estimate the types and numbers of samples required for physical samples, or equivalent information for studies using survey and interview techniques.
3. Describe the procedures for the handling and custody of samples, including sample collection, identification, preservation, transportation, and storage.
4. Describe the procedures that will be used in the calibration and performance evaluation of all analytical instrumentation and all methods of analysis to be used during the project. Explain how the effectiveness of any new technology will be measured and how it will be benchmarked to improve an existing process, such as those used by industry.
5. Discuss the procedures for data reduction and reporting, including a description of all statistical methods with reference to any statistical software to be used to make inferences and conclusions. Discuss any computer models to be designed or utilized with associated verification and validation techniques.
6. Describe the quantitative and/or qualitative procedures that will be used to evaluate the success of the project, including any plans for peer or other reviews of the study design or analytical methods prior to data collection.
ANSI/ASQC E4, "Specifications and Guidelines for Quality Systems for Environmental Data Collection and Environmental Technology Programs," is available for purchase from the American Society for Quality, phone 1-800-248-1946, item T55. Only in exceptional circumstances should it be necessary to consult this document.
C. Annual Meetings. It is the intent of the NIEHS to hold annual grantee meetings. Funds for travel by appropriate staff (i.e., Principal Investigator, Business Manager, and four students) to attend a three-day meeting shall be included in the Administrative Core’s budget for each year. It is also anticipated that the Outreach Core and Research Translation Core Leaders will convene at the annual meeting, and expenses for this travel should be included in their individual budgets. The location of the meeting site will rotate among the different grantees and Research Triangle Park, NC.
Appendix Materials
All paper PHS 398 applications submitted must provide appendix material on CDs only. Include five identical CDs in the same package with the application. See http://grants.nih.gov/grants/guide/notice-files/NOT-OD-08-031.html.)
Do not use the Appendix to circumvent the page limitations of the Research Plan component. An application that does not observe the required page limitations may be delayed in the review process.
Resource Sharing Plan(s)
NIH considers the sharing of unique research resources developed through NIH-sponsored research an important means to enhance the value of, and advance, research. When resources have been developed with NIH funds and the associated research findings published or provided to NIH, it is important that they be made readily available for research purposes to qualified individuals within the scientific community. If the final data/resources are not amenable to sharing, this must be explained in Resource Sharing section of the application. See http://grants.nih.gov/grants/policy/data_sharing/data_sharing_faqs.htm.
(a) Data Sharing Plan: Regardless of the amount requested, investigators are expected to include a brief 1-paragraph description of how final research data will be shared, or explain why data-sharing is not possible. Applicants are encouraged to discuss data-sharing plans with their NIH program contact. See Data-Sharing Policy or http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-032.html.
(b) Sharing Model Organisms: Regardless of the amount requested, all applications where the development of model organisms is anticipated are expected to include a description of a specific plan for sharing and distributing unique model organisms and related resources, or state appropriate reasons why such sharing is restricted or not possible. See Sharing Model Organisms Policy, and NIH Guide NOT-OD-04-042.
(c) Genome-Wide Association Studies (GWAS): Regardless of the amount requested, applicants seeking funding for a genome-wide association study are expected to provide a plan for submission of GWAS data to the NIH-designated GWAS data repository, or provide an appropriate explanation why submission to the repository is not possible. A genome-wide association study is defined as any study of genetic variation across the entire genome that is designed to identify genetic associations with observable traits (such as blood pressure or weight) or the presence or absence of a disease or condition. For further information see Policy for Sharing of Data Obtained in NIH Supported or Conducted Genome-Wide Association Studies, NIH Guide NOT-OD-07-088, and http://grants.nih.gov/grants/gwas/.
Section V. Application Review Information
1.
Criteria (Update: Enhanced review criteria have been issued for the evaluation of research applications received for potential FY2010 funding and thereafter - see NOT-OD-09-025).
Only the review criteria
described below will be considered in the review process.
2.
Review and Selection Process
Applications that are complete
and responsive to the FOA will be evaluated for scientific and technical merit
by an appropriate peer review group convened by the National Institute of
Environmental Health Sciences and in accordance with NIH peer review procedures
(http://grants1.nih.gov/grants/peer/),
using the review criteria stated below.
As part of the scientific peer review, all applications will:
The following will be considered in making funding decisions:
The goals of NIH supported research are to advance our understanding of biological systems, to improve the control of disease, and to enhance health. Within this context, the goal of the SBRP is to improve public health by supporting integrative research that is multidisciplinary in nature and includes the ability to identify, assess, and evaluate the potential health effects of exposure to hazardous substances and to develop innovative chemical, physical and biological technologies for reducing potential exposure to hazardous substances.
In their written critiques, reviewers will be asked to comment on each of the following criteria in order to judge the likelihood that the proposed research will have a substantial impact on the pursuit of these goals. Each of these criteria will be addressed and considered in assigning the overall score, and weighted as appropriate for each application. Note that an application does not need to be strong in all categories to be judged likely to have major scientific impact and thus deserve a meritorious priority score. For example, an investigator may propose to carry out important work that by its nature is not innovative but is essential to move a field forward.
The initial review for scientific and technical merit will emphasize two major aspects: (1) the multi-project grant as an integrated research effort of projects and support cores focused on a central theme; and (2) the review of each research project, research support core and other core components independently.
The scientific review panel will evaluate the scientific merit of the program as a whole, as well as the inter-relationship and contributions of the research projects and cores to an overall conceptual theme.
Review Criteria for the Overall SBRP Application
The overall multi-project grant application will be based on the following criteria:
Significance: Does the overall program address an important problem? If the aims of the application are achieved, how will scientific knowledge or clinical practice be advanced? What will be the effect of these studies on the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field?
Approach: Are the conceptual or clinical framework, design, methods, and analyses adequately developed, well integrated, well reasoned, and appropriate to the aims of the project? Does the applicant acknowledge potential problem areas and consider alternative tactics?
Innovation: Is the overall program original and innovative? For example: Does the program challenge existing paradigms or address an innovative hypothesis or critical barrier to progress in the field? Does the program develop or employ novel concepts, approaches, methodologies, tools, or technologies for this area?
Investigators: Are the investigators appropriately trained and well suited to carry out this work? Is the work proposed appropriate to the experience level of the Principal Investigator and other researchers? Does the investigative team bring complementary and integrated expertise to the overall program?
Environment: Does the scientific environment in which the work will be done contribute to the probability of success? Do the proposed studies benefit from unique features of the scientific environment, or subject populations, or employ useful collaborative arrangements? Is there evidence of institutional support?
In addition to the five criteria used to judge the scientific merit of the program as a whole, the following criteria should be considered in reviewing the integration of the overall program.
Multidisciplinary and Interdisciplinary Nature of the Program
Principal Investigator
Review Criteria for Renewal Applications
In addition, for renewal applications the following will be considered:
Review Criteria for the Research Projects
Review of the individual Research Projects is similar to the review of investigator-initiated individual project grant applications (R01). Accordingly, these projects must have substantial scientific merit. Reviewers will evaluate the individual projects against five review criteria. The four technical review criteria (Significance, Approach, Innovation and Environment) are intended to encourage reviewers to focus on the global impacts of each project, rather than concentrating on the experimental details and their critiques. The review criteria are as follows:
Significance: Does this study address an important problem? If the aims of the application are achieved, how will scientific knowledge or clinical practice be advanced? What will be the effect of these studies on the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field? If the study is successful, would it lead to incremental advance, or would it provide a substantial step forward that would likely not be achieved through mechanisms other than this multi-project program? If successful, will the project result in knowledge or resources that could be utilized to improve human health, risk assessment, or improve the quality of the environment?
Approach: Are the conceptual or clinical framework, design, methods, and analyses adequately developed, well integrated, well reasoned, and appropriate to the aims of the project? Does the applicant acknowledge potential problem areas and consider alternative tactics? Is there strong synergy among the combined efforts of the various investigators within the program?
Innovation: Is the project original and innovative? For example: Does the project challenge existing paradigms or clinical practice; address an innovative hypothesis or critical barrier to progress in the field? Does the project develop or employ novel concepts, approaches, methodologies, tools, or technologies for this area?
Investigators: Are the investigators appropriately trained and well suited to carry out this work? Is the work proposed appropriate to the experience level of the principal investigator and other researchers? Does the investigative team bring complementary and integrated expertise to the project (if applicable)?
Environment: Does the scientific environment in which the work will be done contribute to the probability of success? Do the proposed studies benefit from unique features of the scientific environment, or subject populations, or employ useful collaborative arrangements? Is there evidence of institutional support?
In addition to the standard criteria listed above, reviewers will evaluate each project for its contribution to the overall goals of the SBRP application:
In addition to the review criteria described above for research projects, the following will be considered by the review panel in evaluating the cores, the multidisciplinary and interdisciplinary nature of the program and the principal investigator.
Review Criteria for the Research Support Cores
The Research Support Cores will be assessed based on the following criteria:
Review Criteria for the Administrative Core
The Administrative Core will be assessed based on the following criteria:
Review Criteria for the Research Translation Core
The Research Translation Core will be assessed based on the following criteria:
Review Criteria for the Community Outreach Core
The Community Outreach Core will be assessed based on the following criteria:
Review Criteria for the Training Core
The Training Core will be assessed based on the following criteria:
2.A.
Additional Review Criteria:
In addition to the
above criteria, the following items will continue to be considered in the
determination of scientific merit and the rating:
Resubmission
Applications (formerly revised/amended applications): Are the responses to
comments from the previous scientific review group adequate? Are the
improvements in the resubmission application appropriate?
Protection of Human Subjects from Research Risk: The involvement of human
subjects and protections from research risk relating to their participation in
the proposed research will be assessed (see the Research Plan section on Human
Subjects in the PHS 398 instructions).
Inclusion of Women, Minorities and Children in Research: The adequacy of plans to
include subjects from both genders, all racial and ethnic groups (and
subgroups), and children as appropriate for the scientific goals of the
research will be assessed. Plans for the recruitment and retention of subjects
will also be evaluated (see the Research Plan section on Human Subjects in the
PHS 398 instructions).
Care and Use of Vertebrate Animals in Research: If vertebrate animals are to
be used in the project, the five points described in the Vertebrate Animals
section of the Research Plan will be assessed.
Biohazards: If materials or procedures are proposed that are
potentially hazardous to research personnel and/or the environment, determine
if the proposed protection is adequate.
2.B.
Additional Review Considerations
Budget: The reasonableness of the
proposed budget and the requested period of support in relation to the proposed
research. The priority score should not be affected by the evaluation of the
budget.
2.C. Resource Sharing Plan(s)
When relevant, reviewers will be instructed to comment on the reasonableness of the following Resource Sharing Plans, or the rationale for not sharing the following types of resources. However, reviewers will not factor the proposed resource sharing plan(s) into the determination of scientific merit or priority score, unless noted otherwise in the FOA. Program staff within the IC will be responsible for monitoring the resource sharing.
3. Anticipated Announcement and Award
Dates
Not
Applicable.
Section
VI. Award Administration Information
1. Award Notices
After the peer review
of the application is completed, the PD/PI will be able to access his or her
Summary Statement (written critique) via the eRA Commons.
If the application is under consideration for funding,
NIH will request "just-in-time" information from the applicant. For
details, applicants may refer to the NIH
Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards,
Subpart A: General.
Selection of an application for award is not an authorization to begin performance. Any costs incurred before receipt of the NoA are at the recipient's risk. These costs may be reimbursed only to the extent considered allowable pre-award costs. See Also Section IV.5. Funding Restrictions.
A formal notification in the form of a Notice of Award (NoA) will be provided to the applicant organization. The NoA signed by the grants management officer is the authorizing document. Once all administrative and programmatic issues have been resolved, the NoA will be generated via email notification from the awarding component to the grantee business official (designated in item 12 on the Application Face Page). If a grantee is not email enabled, a hard copy of the NoA will be mailed to the business official.
Selection of an
application for award is not an authorization to begin performance. Any costs
incurred before receipt of the NoA are at the recipient's risk. These costs may
be reimbursed only to the extent considered allowable pre-award costs. See Also Section IV.5. Funding Restrictions.
2. Administrative and
National Policy Requirements
All NIH grant
and cooperative agreement awards include the NIH Grants Policy Statement as
part of the NoA. For these terms of award, see the NIH Grants Policy Statement
Part II: Terms and Conditions of NIH Grant Awards, Subpart A: General (http://grants.nih.gov/grants/policy/nihgps_2003/NIHGPS_Part4.htm)
and Part II Terms and Conditions of NIH Grant Awards, Subpart B: Terms and
Conditions for Specific Types of Grants, Grantees, and Activities (http://grants.nih.gov/grants/policy/nihgps_2003/NIHGPS_part9.htm).
The following Terms and Conditions will be incorporated into the award statement and will be provided to the Principal Investigator as well as to the appropriate institutional official, at the time of award.
3. Reporting
Awardees will be
required to submit the Non-Competing Continuation
Grant Progress Report (PHS 2590) annually and financial statements as
required in the NIH Grants
Policy Statement.
A final progress report, invention statement, and Financial Status Report are required when an award is relinquished when a recipient changes institutions or when an award is terminated.
We
encourage your inquiries concerning this funding opportunity and welcome the
opportunity to answer questions from potential applicants. Because of the complexity of the SBRP, applicants
are strongly encouraged to contact NIEHS staff early in the grant preparation
process. Inquiries may fall into three areas: scientific/research, peer
review, and financial or grants management issues:
1. Scientific/Research Contacts:
Claudia Thompson, Ph.D.
Center for Risk and Integrated Sciences
Division of Extramural Research and Training
National Institute of Environmental Health
Sciences
P.O. Box 12233 MD EC-27
Research Triangle Park, NC 27709
Telephone: 919-541-4638
FAX: 919-541-4937
Email: [email protected]
Heather Henry, Ph.D.
Center for Risk and Integrated Sciences
Division of Extramural Research and Training
National Institute of Environmental Health
Sciences
P.O. Box 12233 MD EC-27
Research Triangle Park, NC 27709
Telephone: 919-541-5330
FAX: 919-541-4937
Email: [email protected]
Beth Anderson, M.A.
Center for Risk and Integrated Sciences
Division of Extramural Research and Training
National Institute of Environmental Health
Sciences
P.O. Box 12233 MD EC-27
Research Triangle Park, NC 27709
Telephone: 919-541-4481
FAX: 919-541-4937
Email: [email protected]
2. Peer Review Contacts:
Leroy
Worth, Ph.D.
Scientific Review Branch
Division of Extramural Research and Training
National Institute of Environmental Health Sciences
PO Box 12233, EC-30
111 T.W. Alexander Drive
Research Triangle Park, NC 27709
Telephone: (919) 541-0670
FAX: (919) 541-2503
Email: [email protected]
Sally
Eckert-Tilotta, Ph.D.
Scientific Review Branch
Division of Extramural Research and Training
National Institute of Environmental Health Sciences
PO Box 12233, EC-30
111 T.W. Alexander Drive
Research Triangle Park, NC 27709
Telephone: (919) 541-1446
FAX: (919) 541-2503
Email: [email protected]
3. Financial or Grants Management
Contacts:
Susan Ricci
Grants Management Branch
Division of Extramural Research and Training
National Institute of Environmental Health
Sciences
P.O. Box 12233, EC-30
Research Triangle Park, North Carolina 27709
Telephone: 919-316-4666
Fax: 301-451-5334
E-mail: [email protected]
Lisa Archer Edwards
Grants Management Branch
Division of Extramural Research and Training
National Institute of Environmental Health
Sciences
P.O. Box 12233, EC-30
Research Triangle Park, North Carolina 27709
Telephone: 919-541-0751
Fax: 301-451-5334
E-mail: [email protected]
Section VIII. Other Information
Required
Federal Citations
Use of Animals in
Research:
Recipients of PHS support for activities involving
live, vertebrate animals must comply with PHS Policy on Humane Care and Use of
Laboratory Animals (http://grants.nih.gov/grants/olaw/references/PHSPolicyLabAnimals.pdf)
as mandated by the Health Research Extension Act of 1985 (http://grants.nih.gov/grants/olaw/references/hrea1985.htm),
and the USDA Animal Welfare Regulations (http://www.nal.usda.gov/awic/legislat/usdaleg1.htm)
as applicable.
Human Subjects Protection:
Federal regulations (45CFR46) require that
applications and proposals involving human subjects must be evaluated with
reference to the risks to the subjects, the adequacy of protection against
these risks, the potential benefits of the research to the subjects and others,
and the importance of the knowledge gained or to be gained (http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm).
Data and Safety Monitoring Plan:
Data and safety monitoring is required for all types
of clinical trials, including physiologic toxicity and dose-finding studies
(phase I); efficacy studies (Phase II); efficacy, effectiveness and comparative
trials (Phase III). Monitoring should be commensurate with risk. The
establishment of data and safety monitoring boards (DSMBs) is required for
multi-site clinical trials involving interventions that entail potential risks to
the participants (NIH Policy for Data and Safety Monitoring, NIH Guide for Grants and Contracts, http://grants.nih.gov/grants/guide/notice-files/not98-084.html).
Sharing Research Data:
Investigators submitting an NIH application seeking
$500,000 or more in direct costs in any single year are expected to include a
plan for data sharing or state why this is not possible (http://grants.nih.gov/grants/policy/data_sharing).
Investigators should seek guidance from their
institutions, on issues related to institutional policies and
local IRB rules, as well as local, State and Federal laws and regulations,
including the Privacy Rule. Reviewers will consider the data sharing plan
but will not factor the plan into the determination of the scientific merit or
the priority score.
Policy for Genome-Wide
Association Studies (GWAS):
NIH is interested in advancing genome-wide association
studies (GWAS) to identify common genetic factors that influence health and
disease through a centralized GWAS data repository. For the purposes of this
policy, a genome-wide association study is defined as any study of genetic
variation across the entire human genome that is designed to identify genetic
associations with observable traits (such as blood pressure or weight), or the
presence or absence of a disease or condition. All applications, regardless of
the amount requested, proposing a genome-wide association study are expected to
provide a plan for submission of GWAS data to the NIH-designated GWAS data
repository, or provide an appropriate explanation why submission to the
repository is not possible. Data repository management (submission and access)
is governed by the Policy for Sharing of Data Obtained in NIH Supported or
Conducted Genome-Wide Association Studies, NIH Guide NOT-OD-07-088.
For additional information, see http://grants.nih.gov/grants/gwas/
Sharing of Model Organisms:
NIH is committed to support efforts that encourage
sharing of important research resources including the sharing of model
organisms for biomedical research (see http://grants.nih.gov/grants/policy/model_organism/index.htm).
At the same time the NIH recognizes the rights of grantees and contractors to
elect and retain title to subject inventions developed with Federal funding
pursuant to the Bayh Dole Act (see the NIH Grants Policy Statement http://grants.nih.gov/grants/policy/nihgps_2003/index.htm).
All investigators submitting an NIH application or contract proposal, beginning
with the October 1, 2004 receipt date, are expected to include in the
application/proposal a description of a specific plan for sharing and
distributing unique model organism research resources generated using NIH
funding or state why such sharing is restricted or not possible. This will
permit other researchers to benefit from the resources developed with public
funding. The inclusion of a model organism sharing plan is not subject to a
cost threshold in any year and is expected to be included in all applications
where the development of model organisms is anticipated.
Access to Research Data through the Freedom of
Information Act:
The Office of Management and Budget (OMB) Circular
A-110 has been revised to provide access to research data through the Freedom
of Information Act (FOIA) under some circumstances. Data that are (1) first
produced in a project that is supported in whole or in part with Federal funds
and (2) cited publicly and officially by a Federal agency in support of an
action that has the force and effect of law (i.e., a regulation) may be
accessed through FOIA. It is important for applicants to understand the basic
scope of this amendment. NIH has provided guidance at http://grants.nih.gov/grants/policy/a110/a110_guidance_dec1999.htm.
Applicants may wish to place data collected under this funding opportunity in a
public archive, which can provide protections for the data and manage the
distribution for an indefinite period of time. If so, the application should
include a description of the archiving plan in the study design and include
information about this in the budget justification section of the application.
In addition, applicants should think about how to structure informed consent
statements and other human subjects procedures given the potential for wider
use of data collected under this award.
Inclusion of Women And Minorities in Clinical
Research:
It is the policy of the NIH that women and members of
minority groups and their sub-populations must be included in all NIH-supported
clinical research projects unless a clear and compelling justification is
provided indicating that inclusion is inappropriate with respect to the health
of the subjects or the purpose of the research. This policy results from the
NIH Revitalization Act of 1993 (Section 492B of Public Law 103-43). All
investigators proposing clinical research should read the "NIH Guidelines for Inclusion of Women and Minorities as Subjects in Clinical Research (http://grants.nih.gov/grants/guide/notice-files/NOT-OD-02-001.html);
a complete copy of the updated Guidelines is available at http://grants.nih.gov/grants/funding/women_min/guidelines_amended_10_2001.htm.
The amended policy incorporates: the use of an NIH definition of clinical
research; updated racial and ethnic categories in compliance with the new OMB
standards; clarification of language governing NIH-defined Phase III clinical
trials consistent with the new PHS Form 398; and updated roles and
responsibilities of NIH staff and the extramural community. The policy
continues to require for all NIH-defined Phase III clinical trials that: (a)
all applications or proposals and/or protocols must provide a description of
plans to conduct analyses, as appropriate, to address differences by sex/gender
and/or racial/ethnic groups, including subgroups if applicable; and (b)
investigators must report annual accrual and progress in conducting analyses,
as appropriate, by sex/gender and/or racial/ethnic group differences.
Inclusion of Children as Participants in Clinical
Research:
The NIH maintains a policy that children (i.e.,
individuals under the age of 21) must be included in all clinical research,
conducted or supported by the NIH, unless there are scientific and ethical
reasons not to include them. All investigators proposing research involving
human subjects should read the "NIH Policy and Guidelines" on the
inclusion of children as participants in research involving human subjects (http://grants.nih.gov/grants/funding/children/children.htm).
Required Education on the Protection of Human Subject
Participants:
NIH policy requires education on the protection of
human subject participants for all investigators submitting NIH applications
for research involving human subjects and individuals designated as key
personnel. The policy is available at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-00-039.html.
Human Embryonic Stem Cells (hESC):
Criteria for federal funding of research on hESCs can
be found at http://stemcells.nih.gov/index.asp and at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-02-005.html.
Only research using hESC lines that are registered in the NIH Human Embryonic
Stem Cell Registry will be eligible for Federal funding (http://escr.nih.gov/). It is the responsibility
of the applicant to provide in the project description and elsewhere in the
application as appropriate, the official NIH identifier(s) for the hESC line(s)
to be used in the proposed research. Applications that do not provide this
information will be returned without review.
NIH
Public Access Policy Requirement:
In accordance with the NIH Public Access Policy (http://grants.nih.gov/grants/guide/notice-files/NOT-OD-08-033.html),
investigators must submit or have submitted for them their final, peer-reviewed
manuscripts that arise from NIH funds and are accepted for publication as of
April 7, 2008 to PubMed Central (http://www.pubmedcentral.nih.gov/), to be made publicly
available no later than 12 months after publication. As of May 27, 2008,
investigators must include the PubMed Central reference number when citing an
article in NIH applications, proposals, and progress reports that fall under
the policy, and was authored or co-authored by the investigator or arose from
the investigator’s NIH award. For more information, see the Public Access
webpage at http://publicaccess.nih.gov/.
Standards for Privacy of Individually Identifiable
Health Information:
The Department of
Health and Human Services (DHHS) issued final modification to the
"Standards for Privacy of Individually Identifiable Health
Information", the "Privacy Rule", on August 14, 2002. The
Privacy Rule is a federal regulation under the Health Insurance Portability and
Accountability Act (HIPAA) of 1996 that governs the protection of individually
identifiable health information, and is administered and enforced by the DHHS
Office for Civil Rights (OCR).
Decisions about
applicability and implementation of the Privacy Rule reside with the researcher
and his/her institution. The OCR website (http://www.hhs.gov/ocr/)
provides information on the Privacy Rule, including a complete Regulation Text
and a set of decision tools on "Am I a covered entity?" Information
on the impact of the HIPAA Privacy Rule on NIH processes involving the review,
funding, and progress monitoring of grants, cooperative agreements, and
research contracts can be found at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-025.html.
URLs in NIH Grant
Applications or Appendices:
All applications and proposals for NIH funding must be self-contained within
specified page limitations. For publications listed in the appendix and/or
Progress report, internet addresses (URLs) must be used for publicly accessible on-line journal articles. Unless otherwise specified in this solicitation, Internet addresses (URLs) should not be used to provide
any other information necessary for the review because reviewers are
under no obligation to view the Internet sites. Furthermore, we caution
reviewers that their anonymity may be compromised when they directly access an
Internet site.
Healthy People 2010:
The Public
Health Service (PHS) is committed to achieving the health promotion and disease
prevention objectives of "Healthy People 2010," a PHS-led national
activity for setting priority areas. This FOA is related to one or more of the
priority areas. Potential applicants may obtain a copy of "Healthy People
2010" at http://www.health.gov/healthypeople.
Authority and Regulations:
This program is
described in the Catalog of Federal Domestic Assistance at http://www.cfda.gov/ and is not subject to the
intergovernmental review requirements of Executive Order 12372. Awards are made under authority of the Superfund Amendments
and Reauthorization Act of 1986, Title 1, Section III, and Title II, Section
209 (Public Law 99-499); and are made under the authorization of Sections 301
and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and
under Federal Regulations 42 CFR 52 and 45 CFR Parts 74 and 92. All awards are
subject to the terms and conditions, cost principles, and other considerations
described in the NIH Grants Policy Statement. The NIH Grants Policy
Statement can be found at http://grants.nih.gov/grants/policy/policy.htm.
The PHS strongly encourages all grant recipients to provide a smoke-free workplace and discourage the use of all tobacco products. In addition, Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking in certain facilities (or in some cases, any portion of a facility) in which regular or routine education, library, day care, health care, or early childhood development services are provided to children. This is consistent with the PHS mission to protect and advance the physical and mental health of the American people.
Loan Repayment Programs:
NIH encourages
applications for educational loan repayment from qualified health professionals
who have made a commitment to pursue a research career involving clinical,
pediatric, contraception, infertility, and health disparities related areas.
The LRP is an important component of NIH's efforts to recruit and retain the
next generation of researchers by providing the means for developing a research
career unfettered by the burden of student loan debt. Note that an NIH grant is
not required for eligibility and concurrent career award and LRP applications
are encouraged. The periods of career award and LRP award may overlap providing
the LRP recipient with the required commitment of time and effort, as LRP
awardees must commit at least 50% of their time (at least 20 hours per week
based on a 40 hour week) for two years to the research. For further
information, please see: http://www.lrp.nih.gov/.
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
| ||||||
Department of Health and Human Services (HHS) |
||||||
NIH... Turning Discovery Into Health® |